99 related articles for article (PubMed ID: 24481321)
1. Impact of test methodology, media type and ion content on the susceptibility of Acinetobacter spp. to tigecycline.
Qu J; Zong Z; Yu R; Hu T; Ye H; Lü X
J Antimicrob Chemother; 2014 Jun; 69(6):1710-1. PubMed ID: 24481321
[No Abstract] [Full Text] [Related]
2. The susceptibility to tigecycline of Acinetobacter spp. may vary depending on the methodology used.
Zárate MS; Serruto G; Smayevsky J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e351-2. PubMed ID: 20031463
[No Abstract] [Full Text] [Related]
3. Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
Curcio D; Fernández F; Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Sader HS
J Clin Microbiol; 2007 Jun; 45(6):2095; author reply 2095-6. PubMed ID: 17548459
[No Abstract] [Full Text] [Related]
4. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
Park YK; Choi JY; Song JH; Ko KS
Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
[No Abstract] [Full Text] [Related]
5. Comment on: Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.
Curcio D; Fernández F
J Antimicrob Chemother; 2008 Nov; 62(5):1166-7. PubMed ID: 18689874
[No Abstract] [Full Text] [Related]
6. Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.
Thamlikitkul V; Tiengrim S
J Antimicrob Chemother; 2008 Oct; 62(4):847-8. PubMed ID: 18567913
[No Abstract] [Full Text] [Related]
7. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.
Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Swenson JM; Sader HS
J Clin Microbiol; 2007 Jan; 45(1):227-30. PubMed ID: 17093026
[TBL] [Abstract][Full Text] [Related]
8. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective.
Curcio D; Fernández F
J Antimicrob Chemother; 2007 Aug; 60(2):449-50. PubMed ID: 17561503
[No Abstract] [Full Text] [Related]
9. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
Tan TY; Ng LS; Chen DM
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
[No Abstract] [Full Text] [Related]
11. Susceptibility testing of tigecycline against Acinetobacter spp. by disc diffusion method: withdrawing a therapeutic option by varying the Mueller-Hinton agar?
Canigia LF; Bantar C
J Antimicrob Chemother; 2008 Dec; 62(6):1463-4. PubMed ID: 18782779
[No Abstract] [Full Text] [Related]
12. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).
Mendes RE; Farrell DJ; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):307-11. PubMed ID: 20955916
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline susceptibility in multidrug resistant Acinetobacter isolates from Turkey.
Yilmaz FF; Taşli H; Gül-Yurtsever S; Büyük A; Hoşgör-Limoncu M
Pol J Microbiol; 2013; 62(3):295-8. PubMed ID: 24459835
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
Eser OK; Ergin A; Tunçkanat F; Hasçelik G
New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
[TBL] [Abstract][Full Text] [Related]
15. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
[TBL] [Abstract][Full Text] [Related]
16. Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Thamlikitkul V; Tiengrim S; Tribuddharat C
J Antimicrob Chemother; 2007 Jul; 60(1):177-8; author reply 178-9. PubMed ID: 17496287
[No Abstract] [Full Text] [Related]
17. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of tigecycline and comparators on Acinetobacter spp. isolates collected from patients with bacteremia and MIC change during the Tigecycline Evaluation and Surveillance Trial, 2004 to 2008.
Wang YF; Dowzicky MJ
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):73-9. PubMed ID: 20727474
[TBL] [Abstract][Full Text] [Related]
19. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii.
Hawser SP; Hackel M; Person MB; Higgins PG; Seifert H; Dowzicky M
Int J Antimicrob Agents; 2010 Sep; 36(3):289-90. PubMed ID: 20558046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
